ATE541040T1 - Pim-3 kinase als ziel für type 2 diabetes mellitus - Google Patents

Pim-3 kinase als ziel für type 2 diabetes mellitus

Info

Publication number
ATE541040T1
ATE541040T1 AT03701530T AT03701530T ATE541040T1 AT E541040 T1 ATE541040 T1 AT E541040T1 AT 03701530 T AT03701530 T AT 03701530T AT 03701530 T AT03701530 T AT 03701530T AT E541040 T1 ATE541040 T1 AT E541040T1
Authority
AT
Austria
Prior art keywords
pim
type
diabetes mellitus
kinase
target
Prior art date
Application number
AT03701530T
Other languages
English (en)
Inventor
Marcus Korn
Guenter Mueller
Rudolf Schneider
Georg Tschank
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of ATE541040T1 publication Critical patent/ATE541040T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03701530T 2002-01-19 2003-01-20 Pim-3 kinase als ziel für type 2 diabetes mellitus ATE541040T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02001401 2002-01-19
PCT/EP2003/000492 WO2003060130A2 (en) 2002-01-19 2003-01-20 Pim-3 kinase as a target for type 2 diabetes mellitus

Publications (1)

Publication Number Publication Date
ATE541040T1 true ATE541040T1 (de) 2012-01-15

Family

ID=8185311

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03701530T ATE541040T1 (de) 2002-01-19 2003-01-20 Pim-3 kinase als ziel für type 2 diabetes mellitus

Country Status (14)

Country Link
EP (1) EP1468092B1 (de)
JP (1) JP4272533B2 (de)
KR (2) KR101158326B1 (de)
CN (1) CN100467601C (de)
AT (1) ATE541040T1 (de)
BR (1) BR0306984A (de)
CA (2) CA2680946C (de)
DK (1) DK1468092T3 (de)
IL (1) IL194074A (de)
MX (1) MXPA04006906A (de)
NO (1) NO333253B1 (de)
RU (1) RU2316598C2 (de)
WO (1) WO2003060130A2 (de)
ZA (1) ZA200404997B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080096833A1 (en) * 2003-08-11 2008-04-24 Naofumi Mukaida Polytpeptide Specific To Liver Cancer, Polynucleotide Coding For The Polypeptide, And Rna Molecule Inhibiting Expression Of The Polypeptide
AU2020302043B2 (en) * 2019-06-27 2024-10-03 Dnt Co., Ltd. Novel ADP-ribosyl cyclase and inhibitor thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2158544C (en) * 1993-03-19 2007-10-09 Cornelia Lechner Extracellular signal-regulated kinase, sequences, and methods of production and use
RU2054936C1 (ru) * 1994-04-07 1996-02-27 Елизарова Евгения Павловна Мембраностабилизирующее средство для лечения больных с инсулинзависимым и инсулиннезависимым сахарным диабетом
EP0911391A3 (de) * 1997-10-24 2000-01-19 Smithkline Beecham Corporation Klon HWHHJ20
US6143540A (en) * 1999-01-26 2000-11-07 Millennium Pharmaceuticals, Inc. Molecules of the HKID-1-related protein family and uses thereof
WO2000075667A1 (en) * 1999-06-04 2000-12-14 Kinetek Pharmaceuticals, Inc. Assay for detecting the enzymatic activity of a phosphorylation enzyme using enhanced signal generation
CN1328134A (zh) * 2001-04-13 2001-12-26 复旦大学 一种蛋白激酶编码序列,其编码的多肽、制法及用途
DE10123055A1 (de) * 2001-05-11 2003-03-20 Gruenenthal Gmbh Screeningverfahren mit PIM1-Kinase oder PIM3-Kinase

Also Published As

Publication number Publication date
BR0306984A (pt) 2004-12-14
NO20043459L (no) 2004-10-07
JP4272533B2 (ja) 2009-06-03
MXPA04006906A (es) 2004-12-06
AU2003202579A1 (en) 2003-07-30
KR20040075940A (ko) 2004-08-30
WO2003060130A3 (en) 2004-01-15
KR101205194B1 (ko) 2012-11-27
NO333253B1 (no) 2013-04-22
EP1468092B1 (de) 2012-01-11
DK1468092T3 (da) 2012-05-07
KR20110011753A (ko) 2011-02-08
CA2680946C (en) 2013-03-12
EP1468092A2 (de) 2004-10-20
CA2473566C (en) 2012-05-01
CN100467601C (zh) 2009-03-11
CN1620505A (zh) 2005-05-25
JP2005514068A (ja) 2005-05-19
RU2004125291A (ru) 2005-04-20
WO2003060130A2 (en) 2003-07-24
CA2680946A1 (en) 2003-07-24
KR101158326B1 (ko) 2012-06-28
CA2473566A1 (en) 2003-07-24
RU2316598C2 (ru) 2008-02-10
IL194074A (en) 2011-08-31
ZA200404997B (en) 2006-05-31

Similar Documents

Publication Publication Date Title
BR0009505A (pt) Compostos e processos para terapia e diagnóstico de câncer de pulmão
ATE499382T1 (de) Generierung künstlicher bindungsproteine auf der grundlage von ubiquitin-proteinen
WO2003035846A3 (en) Structure of tall-1 and its cognate receptor
TR200003159T2 (tr) Antipicornaviral bileşikler, hazırlanışları ve kullanımları
WO2004050704A8 (en) Therapeutic and diagnostic agents
BRPI0412607A (pt) método para aprimorar a eficácia de proteìnas modificantes de reação biológica e muteìnas resultantes
Omran et al. Targeting post-translational modifications of the p73 protein: A promising therapeutic strategy for tumors
MXPA05011085A (es) Composiciones y metodos relacionados a stop-1.
BRPI0406680A (pt) Métodos para selecionar um animal para ter propriedades desejadas genotìpicas ou fenotìpicas em potencial, para modular a trascrição de mrna de um gene igf2 em uma célula ou organismo provido com referido gene e para identificar um composto, composto, composição farmacêutica, e, uso de um composto
NO20020470D0 (no) Polymorfier i det humane MDR-1-genet og deres anvendelse i diagnostisk og terapeutiske anvendelser
ATE514718T1 (de) Peptabody für krebsbehandlung
Moral‐Sanz et al. The structural conformation of the tachykinin domain drives the anti‐tumoural activity of an octopus peptide in melanoma BRAFV600E
WO2003078456A3 (en) Human diabetes-mediating proteins
NO20021146L (no) Polymorfier i det humane CYP3A7 og CYP3A7 gener og deres anvendelse i diagnostikk og terapeutiske applikasjoner
DK1468092T3 (da) Pim-3-kinase som et mål for type 2-diabetes mellitus
WO2006000213A3 (de) Peptide zur inhibition der interaktion von proteinkinase a und proteinkinase a-ankerproteinen
DE69920681D1 (de) Humaner k+ ionenkanal und therapeutische verwendungen davon
SE0002189D0 (sv) New method and assay
Dias et al. Profiling the linear peptides of venom from the Brazilian scorpion Tityus serrulatus: structural and functional characterization
BRPI0408778A (pt) proteìnas ativadoras de elemento de resposta à amp cìclica e uso relacionado as mesmas
AU2347501A (en) Trp-protein-related mtr1 protein and dna sequence coding therefor
TW200716749A (en) Interferon-beta gene therapy using an improved, regulated expression system
WO2001029068A3 (en) A eag gene encoding for a potassium channel
BR0015170A (pt) Proteìnas de hcv com oxirredução reversìvel e conformação similar à nativa
WO2003087332A3 (en) Novel polynucleotides encoding the human citron kinase polypeptide, bmsnkc 0020/0021